Pd02-06 comprehensive genomic profiling (cgp) of clinical t2-4n0m0 muscle-invasive bladder cancer (mibc) treated with neoadjuvant pembrolizumab or cisplatin-based chemotherapy before radical cystectomy (rc)
Journal of Urology（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要